Budesonide at different doses for chronic asthma.
暂无分享,去创建一个
P. Jones | N. Adams | J. Bestall | J. Bestall | P. Jones
[1] G. Shapiro,et al. Once-daily budesonide inhalation powder (Pulmicort Turbuhaler) maintains pulmonary function and symptoms of asthmatic children previously receiving inhaled corticosteroids. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[2] R. Dahl,et al. Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function. , 2000, American journal of respiratory and critical care medicine.
[3] B. Lipworth,et al. Effects of once-daily formoterol and budesonide given alone or in combination on surrogate inflammatory markers in asthmatic adults. , 2000, Chest.
[4] T. Miyamoto,et al. A double‐blind, placebo‐controlled dose–response study with budesonide Turbuhaler in Japanese asthma patients , 2000 .
[5] T. Miyamoto,et al. A double‐blind, placebo‐controlled steroid‐sparing study with budesonide Turbuhaler in Japanese oral steroid‐dependent asthma patients , 2000 .
[6] Inman,et al. Effects of once daily dosing with inhaled budesonide on airway hyperresponsiveness and airway inflammation following repeated low‐dose allergen challenge in atopic asthmatics , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[7] C. Jenkins,et al. Optimal asthma control, starting with high doses of inhaled budesonide. , 2000, The European respiratory journal.
[8] H. Puolijoki,et al. Comparison of high and low dose of the inhaled steroid, budesonide, as an initial treatment in newly detected asthma. , 2000, Respiratory medicine.
[9] K. Carlsen,et al. Low‐dose budesonide improves exercise‐induced bronchospasm in schoolchildren , 2000, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[10] B. Lipworth,et al. Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma. , 2000, The American journal of medicine.
[11] A. Foresi,et al. Low-dose budesonide with the addition of an increased dose during exacerbations is effective in long-term asthma control. On behalf of the Italian Study Group. , 2000, Chest.
[12] J. Kemp,et al. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[13] R. Dockhorn,et al. Dose-proportional pharmacokinetics of budesonide inhaled via Turbuhaler. , 1999, British journal of clinical pharmacology.
[14] E. R. Mcfadden,et al. Administration of budesonide once daily by means of turbuhaler to subjects with stable asthma. , 1999, The Journal of allergy and clinical immunology.
[15] R. Pauwels,et al. Systemic effects of inhaled fluticasone propionate and budesonide in adult patients with asthma. , 1999, American journal of respiratory and critical care medicine.
[16] J. Ramsdell,et al. Rapid onset of control with budesonide Turbuhaler in patients with mild-to-moderate asthma. , 1999, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[17] P. Barnes,et al. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma , 1999, Thorax.
[18] B. Lipworth,et al. Dose-response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults. , 1998, The Journal of allergy and clinical immunology.
[19] G. Shapiro,et al. Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid-dependent, persistent asthma. , 1998, The Journal of allergy and clinical immunology.
[20] G. Kollerup,et al. Adverse effects of inhaled budesonide (800 micrograms) on growth and collagen turnover in children with asthma: a double-blind comparison of once-daily versus twice-daily administration. , 1998, The Journal of pediatrics.
[21] K. Carlsen,et al. Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids. , 1998, The European respiratory journal.
[22] D. Cockcroft,et al. Comparison of 3 different doses of budesonide and placebo on the early asthmatic response to inhaled allergen. , 1998, The Journal of allergy and clinical immunology.
[23] L. Campbell,et al. Initial loading (400 micrograms twice daily) versus static (400 micrograms nocte) dose budesonide for asthma management. PLAN Research Group. , 1998, International journal of clinical practice.
[24] O. D. Wolthers,et al. Differential effects of inhaled budesonide on serum osteocalcin in children and adolescents with asthma , 1998, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[25] D. Postma,et al. Starting with a higher dose of inhaled corticosteroids in primary care asthma treatment. , 1998, American journal of respiratory and critical care medicine.
[26] L. Borgström,et al. Lung deposition of budesonide in asthmatics: a comparison of different formulations , 1998 .
[27] S. Szefler,et al. Dose-related efficacy of budesonide administered via a dry powder inhaler in the treatment of children with moderate to severe persistent asthma. , 1998, The Journal of pediatrics.
[28] J. P. Powell,et al. Once-daily budesonide: 400 micrograms once daily is as effective as 200 micrograms twice daily in controlling childhood asthma. PETITE Research Group. , 1998, International journal of clinical practice.
[29] S. Spector,et al. Oral glucocorticosteroid-sparing effect of budesonide administered by Turbuhaler: a double-blind, placebo-controlled study in adults with moderate-to-severe chronic asthma. Pulmicort Turbuhaler Study Group. , 1998, Chest.
[30] H. Blau,et al. Rapid induction of clinical response with a short-term high-dose starting schedule of budesonide nebulizing suspension in young children with recurrent wheezing episodes. , 1998, The Journal of allergy and clinical immunology.
[31] T L Petty,et al. Budesonide delivered by Turbuhaler is effective in a dose-dependent fashion when used in the treatment of adult patients with chronic asthma. , 1998, The Journal of allergy and clinical immunology.
[32] F. Dekker,et al. Once-daily budesonide in mild asthma. , 1998, Respiratory medicine.
[33] R. Dockhorn,et al. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study. , 1998, The Journal of allergy and clinical immunology.
[34] L. Borgström,et al. The effects of static charge in spacer devices on glucocorticosteroid aerosol deposition in asthmatic patients. , 1998, The European respiratory journal.
[35] H. Bisgaard,et al. Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics. , 1998, Respiratory medicine.
[36] D. Postma,et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. , 1997, The New England journal of medicine.
[37] S. Pedersen,et al. Short-term knemometry and urine cortisol excretion in children treated with fluticasone propionate and budesonide: a dose response study. , 1997, The European respiratory journal.
[38] L. Agertoft,et al. Dose titration of nebulized budesonide in young children , 1997, Pediatric pulmonology.
[39] J. Baskerville,et al. Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler. , 1997, The Journal of allergy and clinical immunology.
[40] R. Pauwels,et al. A 1-year comparison of turbuhaler vs pressurized metered-dose inhaler in asthmatic patients. , 1996, Chest.
[41] R. Dahl,et al. Eosinophil and neutrophil activity in asthma in a one-year trial with inhaled budesonide. The impact of smoking. , 1996, American journal of respiratory and critical care medicine.
[42] G. Wennergren,et al. Nebulized budesonide for the treatment of moderate to severe asthma in infants and toddlers * , 1996, Acta paediatrica.
[43] A R Jadad,et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? , 1996, Controlled clinical trials.
[44] M. Marty,et al. Influence du dispositif d'inhalation sur la qualité de vie des patients asthmatiques : substitution des aérosols doseurs habituels par le Turbuhaler® , 1996 .
[45] H. Bisgaard. A metal aerosol holding chamber devised for young children with asthma. , 1995, The European respiratory journal.
[46] S. Pedersen,et al. Measures of systemic activity of inhaled glucocorticosteroids in children: a comparison of urine cortisol excretion and knemometry. , 1995, Respiratory medicine.
[47] A. Juul,et al. The insulin–like growth factor axis and collagen turnover in asthmatic children treated with inhaled budesonide , 1995, Acta paediatrica.
[48] M. Nieminen,et al. Inhalation treatment with budenoside in asthma : a comparison of Turbuhaler® and metered dose inhalation with Nebuhaler® , 1995 .
[49] S. Pedersen,et al. Budesonide treatment of moderate and severe asthma in children: a dose-response study. , 1995, The Journal of allergy and clinical immunology.
[50] S. Pedersen,et al. Influence of spacer device on drug delivery to young children with asthma. , 1994, Archives of disease in childhood.
[51] S. Pedersen,et al. [Budesonide administered via Turbuhaler and a nebulator]. , 1994, Ugeskrift for laeger.
[52] S. Pedersen,et al. The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a Turbuhaler. , 1993, British journal of clinical pharmacology.
[53] S. Pedersen,et al. Importance of the inhalation device on the effect of budesonide. , 1993, Archives of disease in childhood.
[54] S. Pedersen,et al. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids. , 1992, Pediatrics.
[55] S. Pedersen,et al. Growth of asthmatic children during treatment with budesonide: a double blind trial. , 1991, BMJ.
[56] H. Bisgaard,et al. Adrenal Function in Asthmatic Children Treated with Inhaled Budesonide , 1991, Acta paediatrica Scandinavica.
[57] E. Juniper,et al. Long-term effects of budesonide on airway responsiveness and clinical asthma severity in inhaled steroid-dependent asthmatics. , 1990, The European respiratory journal.
[58] B. Karlson,et al. Comparison of dose‐response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma , 1989, Allergy.
[59] K. Nikander,et al. Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler® , 1989, Allergy.
[60] R. Dahl,et al. A double‐blind dose‐response study of budesonide by inhalation in patients with bronchial asthma , 1988, Allergy.
[61] H. Sluiter,et al. Dosage and time effects of inhaled budesonide on bronchial hyperreactivity. , 1988, The American review of respiratory disease.
[62] A. Lahdensuo,et al. Effect of inhaled budesonide on severe steroid-dependent asthma. , 1987, European journal of respiratory diseases.
[63] J. Reiser,et al. The potential value of a 750‐ml spacer for the administration of inhaled corticosteroids to children , 1986, Pediatric pulmonology.
[64] B. Weeke,et al. High-dose inhaled budesonide in treatment of severe steroid-dependent asthma. , 1986, European journal of respiratory diseases.
[65] J. Baskerville,et al. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. , 2015, The American review of respiratory disease.
[66] R. Cayton,et al. Therapeutic advantages of twice-daily over four-times daily inhalation budesonide in the treatment of chronic asthma. , 1984, European journal of respiratory diseases.
[67] J. Baskerville,et al. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. , 1982, The Journal of allergy and clinical immunology.
[68] J. Baskerville,et al. Clinical use of spacer systems for corticosteroid inhalation therapy: a preliminary analysis. , 1982, European journal of respiratory diseases. Supplement.